189 related articles for article (PubMed ID: 8796998)
1. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression.
DeClerck YA; Laug WE
Enzyme Protein; 1996; 49(1-3):72-84. PubMed ID: 8796998
[TBL] [Abstract][Full Text] [Related]
2. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.
Baricos WH; Cortez SL; el-Dahr SS; Schnaper HW
Kidney Int; 1995 Apr; 47(4):1039-47. PubMed ID: 7540230
[TBL] [Abstract][Full Text] [Related]
3. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
Festuccia C; Dolo V; Guerra F; Violini S; Muzi P; Pavan A; Bologna M
Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599
[TBL] [Abstract][Full Text] [Related]
5. Proteases and protease inhibitors in tumor progression.
DeClerck YA; Imren S; Montgomery AM; Mueller BM; Reisfeld RA; Laug WE
Adv Exp Med Biol; 1997; 425():89-97. PubMed ID: 9433492
[TBL] [Abstract][Full Text] [Related]
6. What structure and function of avian plasminogen activator and matrix metalloproteinase-2 reveal about their counterpart mammalian enzymes, their regulation and their role in tumor invasion.
Alexander DS; Aimes RT; Quigley JP
Enzyme Protein; 1996; 49(1-3):38-58. PubMed ID: 8796996
[TBL] [Abstract][Full Text] [Related]
7. Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity.
Tsuboi R; Rifkin DB
Int J Cancer; 1990 Jul; 46(1):56-60. PubMed ID: 2142142
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.
Shirasuna K; Saka M; Hayashido Y; Yoshioka H; Sugiura T; Matsuya T
Cancer Res; 1993 Jan; 53(1):147-52. PubMed ID: 8380125
[TBL] [Abstract][Full Text] [Related]
9. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotide of tissue inhibitor of metalloproteinase-1 induces the plasminogen activator activity in periodontal ligament cells.
Shibata Y; Takiguchi H; Abiko Y
J Periodontol; 1999 Oct; 70(10):1158-65. PubMed ID: 10534069
[TBL] [Abstract][Full Text] [Related]
11. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.
Tyagi SC; Kumar SG; Haas SJ; Reddy HK; Voelker DJ; Hayden MR; Demmy TL; Schmaltz RA; Curtis JJ
J Mol Cell Cardiol; 1996 Jul; 28(7):1415-28. PubMed ID: 8841929
[TBL] [Abstract][Full Text] [Related]
12. Stromal cell expression of components of matrix-degrading protease systems in human cancer.
Hewitt R; Danø K
Enzyme Protein; 1996; 49(1-3):163-73. PubMed ID: 8797004
[TBL] [Abstract][Full Text] [Related]
13. Vascular extracellular matrix remodeling in cerebral aneurysms.
Bruno G; Todor R; Lewis I; Chyatte D
J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
[TBL] [Abstract][Full Text] [Related]
14. Activation of gelatinases by fibrin is PA/plasmin system-dependent in human glomerular endothelial cells.
Cai G; Chen X; Fu B; Lu Y
Mol Cell Biochem; 2005 Sep; 277(1-2):171-9. PubMed ID: 16132729
[TBL] [Abstract][Full Text] [Related]
15. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.
Pepper MS
Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1104-17. PubMed ID: 11451738
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activators and matrix metalloproteinases in angiogenesis.
Mignatti P; Rifkin DB
Enzyme Protein; 1996; 49(1-3):117-37. PubMed ID: 8797002
[TBL] [Abstract][Full Text] [Related]
17. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system.
Smit JW; van der Pluijm G; Romijn HA; Löwik CW; Morreau H; Goslings BM
Thyroid; 1999 Sep; 9(9):913-9. PubMed ID: 10524570
[TBL] [Abstract][Full Text] [Related]
18. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma.
Moser TL; Young TN; Rodriguez GC; Pizzo SV; Bast RC; Stack MS
Int J Cancer; 1994 Feb; 56(4):552-9. PubMed ID: 8112891
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and metastasis.
Kleiner DE; Stetler-Stevenson WG
Cancer Chemother Pharmacol; 1999; 43 Suppl():S42-51. PubMed ID: 10357558
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator expression and matrix degradation.
Rifkin DB
Matrix Suppl; 1992; 1():20-2. PubMed ID: 1480022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
